UA Discovery Shows Curcumin Effect on Colon Cancer

Posted on Sat/12/JulyWed/17/December by AZBio

TUCSON, Ariz. – A team of researchers led by the University of Arizona Steele Children’s Research Center discovered that curcumin—the bioactive molecule derived from the spice turmeric—blocks the protein cortactin in colon cancer.Continue reading→

Seven Arizona Bio and Life Science Companies Receive Fast Grants from ACA

Posted on Fri/11/JulyWed/17/December by AZBio

18 Early Stage Companies Named Recipients of the Arizona Commerce Authority AZ Fast GrantContinue reading→

New Council of International Biotech Associations Formed

Posted on Fri/11/JulyWed/24/June by AZBio

Washington, D.C. (July 10, 2014) –An international confederation of biotechnology trade associations announced today the ratification of bylaws creating the International Council of Biotechnology Associations (ICBA), with the expressed purpose of advocating for public policies that support the growth of the innovative biotechnology industry worldwide.Continue reading→

Ventana Medical Systems, Inc. and Merck KGaA, Darmstadt, Germany to develop companion diagnostic test for cancer treatment

Posted on Thu/10/JulyWed/17/December by AZBio

Ventana Medical Systems, Inc. (Ventana), a member of the Roche Group, today announced it has entered into an agreement with Merck KGaA, Darmstadt, Germany, which operates as EMD Serono in the United States and Canada, to collaborate with Merck KGaA’s biopharmaceutical division on the development and commercialization of a companion diagnostic (CDx) for an undisclosed target using Ventana’s proprietary diagnostic assays.Continue reading→

Survey: Americans Favor Expanded Cord Blood Stem Cell Research

Posted on Thu/10/JulyWed/17/December by AZBio

Far from being sharply divided, the American people are in broad support of more stem cell research, according to the results of an online survey released today by Cord Blood Registry® (CBR®) to coincide with National Cord Blood Awareness Month.Continue reading→

TGen and Ceres Nanosciences announce collaboration to develop high-throughput Nanotrap enrichment methods for Mass Spectrometry

Posted on Thu/10/JulyWed/17/December by AZBio

George Mason University technology supported by National Institutes of Health

Continue reading→

Arizona Rises to Tier II in Bioscience Establishments Ranking.

Posted on Mon/7/JulyWed/17/December by AZBio

Now we need to focus on investments if we are to bring jobs up to the same level.Continue reading→

Medtronic Study Illustrates the Value of Insulin Pumps for Patients with Type 2 Diabetes

Posted on Mon/7/JulyWed/17/December by AZBio

People with Type 2 Diabetes Achieve Superior Outcomes with Insulin Pumps vs. Multiple Daily InjectionsContinue reading→

Ultherapy® Décolletage Treatment Now FDA-Cleared

Posted on Mon/7/JulyWed/17/December by AZBio

First Non-invasive Procedure Specifically Indicated by the FDA to Improve Lines and Wrinkles on the DécolletéContinue reading→

Check out the Program for AdvaMed 2014

Posted on Sat/5/JulyWed/17/December by AZBio

AZBio Members Save 20% with Discount Code AZBIO20

Early Bird Discounts End July 31st. Register Today

Join the Team – Help Make AdvaMed 2014 the Best Yet!

AdvaMed 2014 brings more than 1,000 companies together in North America’s leading MedTech Conference. The AdvaMed 2014 Program Preview is now available with the latest details about program panels, business development, networking opportunities and special programming.The Program Preview also introduces a few of our plenary speakers, including Former Secretary of State Hillary Rodham Clinton, FDA Commissioner Margaret A. Hamburg, Mayor Rahm Emanuel and more!